These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8001262)
1. The sensitivity to camptothecin of DNA topoisomerase I in L5178Y-S lymphoma cells. Staron K; Kowalska-Loth B; Szumiel I Carcinogenesis; 1994 Dec; 15(12):2953-5. PubMed ID: 8001262 [TBL] [Abstract][Full Text] [Related]
2. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases. Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196 [TBL] [Abstract][Full Text] [Related]
3. Reduced sensitivity to camptothecin of topoisomerase I from a L5178Y mouse lymphoma subline sensitive to X-radiation. Kowalska-Loth B; Staron K; Buraczewska I; Szumiel I; Kapiszewska M; Lange CS Biochim Biophys Acta; 1993 Feb; 1172(1-2):117-23. PubMed ID: 8382526 [TBL] [Abstract][Full Text] [Related]
4. Effects of topoisomerase I-targeted drugs on radiation response of L5178Y sublines differentially radiation and drug sensitive. Szumiel I; Buraczewska I; Gradzka I; Gasinska A Int J Radiat Biol; 1995 Apr; 67(4):441-8. PubMed ID: 7738407 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of topoisomerase I in L5178Y-S cells is associated with poly(ADP-ribose) metabolism. Staron K; Kowalska-Loth B; Nieznanski K; Szumiel I Carcinogenesis; 1996 Mar; 17(3):383-7. PubMed ID: 8631120 [TBL] [Abstract][Full Text] [Related]
6. Discrepancy between the initial DNA damage and cell survival after camptothecin treatment in two murine lymphoma L5178Y sublines. Gradzka I; Szumiel I Cell Biochem Funct; 1996 Sep; 14(3):163-71. PubMed ID: 8888569 [TBL] [Abstract][Full Text] [Related]
7. Modulation of the effect of camptothecin in x-irradiated L5178Y-R and L5178Y-S cells by benzamide. Gradzka I; Iwaneńko T; Kruszewski M; Szumiel I; Kapiszewska M; Lange CS; Afanasjev G Radiat Environ Biophys; 1996 Aug; 35(3):185-91. PubMed ID: 8880961 [TBL] [Abstract][Full Text] [Related]
8. DNA repair, cell cycle progression and cell death following camptothecin treatment in two murine lymphoma L5178Y sublines. Gradzka I; Skierski J; Szumiel I Cell Biochem Funct; 1998 Dec; 16(4):239-52. PubMed ID: 9857486 [TBL] [Abstract][Full Text] [Related]
9. Lowered phosphorylation of topoisomerase I is a direct reason for reduced sensitivity of L5178Y-S cells to camptothecin. Staron K; Kowalska-Loth B; Szumiel I Ann N Y Acad Sci; 1996 Dec; 803():321-3. PubMed ID: 8993529 [No Abstract] [Full Text] [Related]
10. Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains. Evans HH; Ricanati M; Horng MF; Mencl J Mutat Res; 1989 Jan; 217(1):53-63. PubMed ID: 2536134 [TBL] [Abstract][Full Text] [Related]
11. Topoisomerase I is differently phosphorylated in two sublines of L5178Y mouse lymphoma cells. Staron K; Kowalska-Loth B; Zabek J; Czerwinski RM; Nieznanski K; Szumiel I Biochim Biophys Acta; 1995 Jan; 1260(1):35-42. PubMed ID: 7999792 [TBL] [Abstract][Full Text] [Related]
12. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content. Eng WK; McCabe FL; Tan KB; Mattern MR; Hofmann GA; Woessner RD; Hertzberg RP; Johnson RK Mol Pharmacol; 1990 Oct; 38(4):471-80. PubMed ID: 2172765 [TBL] [Abstract][Full Text] [Related]
13. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance. Wang LF; Ting CY; Lo CK; Su JS; Mickley LA; Fojo AT; Whang-Peng J; Hwang J Cancer Res; 1997 Apr; 57(8):1516-22. PubMed ID: 9108454 [TBL] [Abstract][Full Text] [Related]
14. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines. Goldwasser F; Bae I; Fornace AJ; Pommier Y Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795 [TBL] [Abstract][Full Text] [Related]
15. Antioxidant defense system in differentially hydrogen peroxide sensitive L5178Y sublines. Bouzyk E; Iwaneńko T; Jarocewicz N; Kruszewski M; Sochanowicz B; Szumiel I Free Radic Biol Med; 1997; 22(4):697-704. PubMed ID: 9013132 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity to inhibitors of type II topoisomerases from mouse L5178Y lymphoma strains that are resistant or sensitive to X-radiation. Staron K; Kowalska-Loth B; Szumiel I; Buraczewska I Mutat Res; 1993 Feb; 285(2):175-9. PubMed ID: 7678889 [TBL] [Abstract][Full Text] [Related]
17. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin. Kapoor R; Slade DL; Fujimori A; Pommier Y; Harker WG Oncol Res; 1995; 7(2):83-95. PubMed ID: 7579731 [TBL] [Abstract][Full Text] [Related]
18. PKA controls a level of topoisomerase I mRNA in mouse L5178Y lymphoma cells treated with db-cAMP. Czerwinski RM; Nieznanski K; Sochanowicz B; Staron K Mol Biol Rep; 1994 Mar; 19(2):93-7. PubMed ID: 8072495 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins. Taniguchi K; Kohno K; Kawanami K; Wada M; Kanematsu T; Kuwano M Cancer Res; 1996 May; 56(10):2348-54. PubMed ID: 8625310 [TBL] [Abstract][Full Text] [Related]
20. Repair of gamma-ray-induced base damage in L5178Y sublines is damage type-dependent and unrelated to radiation sensitivity. Kruszewski M; Zastawny TH; Szumiel I Acta Biochim Pol; 2001; 48(2):525-33. PubMed ID: 11732621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]